Viewing Study NCT02014727


Ignite Creation Date: 2025-12-25 @ 5:06 AM
Ignite Modification Date: 2026-04-05 @ 12:48 AM
Study NCT ID: NCT02014727
Status: COMPLETED
Last Update Posted: 2025-12-04
First Post: 2013-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module